Search our site 
 
Advanced Search
 
Home | Exam dates | Contact us | About us | Testimonials |
 
 

map
You are in Home >> Resources >> Clinical anaesthesia >> ATOTW archive


Perioperative analgesic pharmacology in children

Created: 28/3/2006
Updated: 6/10/2006
 

Perioperative Analgesic Pharmacology in Children



Glyn Williams
Consultant Anaesthetist
willig3@gosh.nhs.uk
Great Ormond Street Hospital for Children NHS Trust


Before reading this tutorial please attempt the questions below, either by yourself or in discussion with your colleagues.

Questions:


1. Name the 4 main classes of analgesic drugs.
2. How does paracetamol work?
3. By what routes may paracetamol be given?
4. What is the oral loading dose of paracetamol?
5. Paracetamol may be used to treat:
a. mild pain?
b. moderate pain?
c. severe pain?
6. How do NSAID’s work
7. In what situations should you be cautious about using NSAID’s?
8. By what routes may NSAID’s be given?
9. Is morphine more or less efficacious in neonates compared with older children? Does that mean you need more or less of it?
10. What are the 2 main potentially serious side effects of opioids?
11. What are the main routes of giving opioids? Discuss the advantages and disadvantages of each route.

Introduction


The inadequate treatment of pain in children following surgery was first highlighted over 20 years ago. A survey at the time found that 40% of paediatric surgical patients experienced moderate or severe postoperative pain and that 75% had insufficient analgesia. Since then increased interest in this area has led to a better understanding of the developmental neurobiology of pain and analgesic pharmacology and, consequently, allowed for the development of safer and more effective analgesic techniques for children of all ages.


Pain Perception



During foetal, neonatal and infant life the nervous system is continually evolving. This allows structural and functional changes to occur continuously in response to the child`s needs as it grows and develops. The pain pathways mirror these changes with different components developing along differing time frames. For instance the structural components required to perceive pain are present from early foetal life wheras pathways involved in modifying pain perception are still developing during infancy. Also opioid and other receptors vary in their number, type and distribution between early life and adulthood.

The challenge of treating pain in these young age groups is to understand how this changing nervous system affects the child`s perception of pain and the efficacy and safety of analgesic treatments. The field is the subject of much research but there are many gaps in our knowledge that need to be filled. Pain is a subjective experience and is thus difficult to assess if communication is not possible. Assessment relies on using non-specific behavioural and hormonal signs of distress/stress. It has been shown in neonates and infants that the use of adequate perioperative analgesia will modify behavioural and hormonal stress responses and reduce morbidity.


Perioperative Pain Management


Successful pain management is based on the formulation of a sensible analgesic plan for each individual patient. It is best to take a practical and pragmatic approach dependent on the patient, the type of surgery and the resources available. Realistic aims are to recognise pain in children, to minimise moderate and severe pain safely in all children, to prevent pain where it is predictable, to bring pain rapidly under control and to continue pain control after discharge from hospital.

Once a pain management plan is implemented it should be regularly reassessed and changes made as required. Appropriate pain assessment is vital to aid this. This should involve clinical assessment of the child and the use of an appropriate pain scoring tool to identify discomfort and monitor the efficacy of any analgesic intervention. Due to the subjective nature of pain and the lack of a reliable measure many different tools are available. If the child is able to communicate their pain then a self reporting score, such as the “pain faces” (see figure 1) should be used. If the child cannot communicate then other tools using behavioural and physiological signs should are appropriate, the one chosen form the many available will depend on the age of the child, their neurological and cognitive state and local preference.

The plan should also include provision for the rapid control of pain that is not alleviated by the original treatment (breakthrough pain) and the identification and treatment of side-effects. In established paediatric centres with high level of resources a dedicated paediatric pain service is the standard of care. Where this is not available significant improvements in pain management can be made by the establishment of clinical routines and protocols for the treatment and assessment of postoperative pain and a network of interested medical and nursing staff to provide ongoing education.



Multimodal Analgesia



Multimodal, or balanced, analgesia, involves the simultaneous use of a number of analgesic interventions to achieve optimal pain management. Our increased understanding of pain biology has allowed us to use analgesic techniques that modify nociceptive transmission at different points along the pain pathway. This produces analgesia using minimal doses of drugs, thereby reducing side-effects.

Using a multimodal approach effective pain management is achievable for most cases and the technique can be adapted for day cases, major cases, the critically ill child, or the very young. In current practice most analgesic techniques are based on differing combinations of four main classes of analgesics: paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and local anaesthetics. Though it is not uncommon for other agents, e.g. NMDA antagonists and a2 agonists, and non pharmacological analgesic methods to be used in addition. Unless there is a contraindication to do so, a local/regional analgesic technique should be used in all cases. For many minor and day case procedures this, in combination with paracetamol and NSAIDs, may allow opioids to be omitted.


Paracetamol (Acetaminophen)

Paracetamol has a mainly central mode of action producing both antipyretic and analgesic effects. It has been shown to inhibit prostaglandin synthesis in the hypothalamus, reduce hyperalgesia mediated by substance P and reduce nitric oxide generation involved in spinal hyperalgesia induced by substance P or NMDA.

It is the most widely prescribed drug in paediatric hospitals and has become the mainstay base analgesic for almost all procedures. The analgesic potency is relatively low and on its own it is only really effective against mild pain. In combination, however, with NSAIDs and weak opioids it has been shown to be effective for moderate pain and it has also been shown to have an opioid sparing effect when used in tandem with the more potent opioids.

The oral bioavailablity of paracetamol is very good as it is rapidly absorbed from the small bowel. Rectal absorption is slow and incomplete, except in neonates. Though the formulations of different brands of suppository vary and the more lipophillic the better the bioavailability. Even so, if paracetamol is given rectally at the start of a short procedure (<1hour) it is unlikely to reach therapeutic plasma levels by the time the child wakes in the recovery room. Thus, if possible, paracetamol should be given orally and pre-operatively. Intravenous paracetamol preparations are becoming widely available in many countries. Studies suggest that it may have a higher analgesic potency than either the oral or rectal preparations though the time to peak analgesia is still 1 – 2 hours. Irrespective of the route of administration a regular rather than an “as required” post-operative prescription has been shown to provide better analgesia.

In recent years the accumulation of a large body of evidence concerning the use of paracetamol in children has led to the revision of dosing schedules to ensure a balance between efficacy and safety. Smaller doses and longer dosage intervals are required in the neonate or sick child.

Paracetamol dosing guide:


Age

Oral

Rectal

Maximum daily dose

Duration at maximum dose

Loading dose

Maintenance dose

Loading dose

Maintenance dose

Pre term <32 weeks

20mg/kg

15mg/kg up to 12 hourly

20mg/kg

15mg/kg up to 12 hourly

45mg/kg/day

48h

32 weeks – 1 month

20mg/kg

15mg/kg up to 6 hourly

30mg/kg

15mg/kg up to 6 hourly

60mg/kg/day

48h

>1month

20mg/kg

15mg/kg up to 4 hourly

30-40 mg/kg

20mg/kg up to 6 hourly

90mg/kg/day

72h



IV Paracetamol dosing guide:

Age/Weight

Dose

Maximum daily dose

1month – 50kg

15mg/kg up to 6 hourly

60mg/kg/day

>50kg

1g up to 6 hourly

4g/day


Non-steroidal anti-inflammatory drugs

NSAIDs act mainly peripherally by inhibiting prostaglandin synthesis and thus reducing inflammation though central effects have also been postulated involving the opioid, serotonin and nitric oxide pathways. They are highly efficacious in their own right in the treatment of mild to moderate pain in children. They have a reported opioid-sparing effect of 30 – 40 % when used in combination with opioids and also reduce opioid-related adverse affects as well as facilitating more rapid weaning of opioid infusions. They have also been shown to be highly effective in combination with local or regional nerve block. Combination with paracetamol produces better analgesia than either drug alone.

There are limitations to their use in paediatric populations. At present, in general, their use is not recommended for children less than 6 months of age, although in the UK Ibuprofen is now available over the counter in formulations for ages 3 months and above. Care should also be taken in those patients who are asthmatic, have a know asprin or NSAID allergy, hypovolaemic or dehydrated, renally-impaired, coagulopathic or where there is a significant risk of haemorrhage. A careful history of previous use of NSAIDs should be taken in every case. Different NSAIDs have different side-effect profiles and the relative risks associated with each of the contraindications given will differ between drugs. In the UK the Committee on the Safety of Medicines has classified Ibuprofen and Diclofenac as having the best side-effects profile.

Pharmacokinetic studies have indicated a higher than expected dose requirement in children if scaled by body weight from adult doses. Rectal and oral bioavailability are both good though again for short cases they are best give orally preoperatively. Other routes of administration are available, such as intravenous and topical, though their use in children has been limited so far.

NSAID dosing guide:

Drug

Route

Dose

Ibuprofen

Oral

<20kg 5-10mg/kgup to 6 hourly

>20kg 200mg6 hourly

Diclofenac

Oral/Rectal

1-3mg/kgup to 3mg/kg in divided doses



Opioids

As with adults, opioids, and morphine in particular, remain the mainstay of analgesic treatment for the majority of all but minor surgical procedures. The choice of which opioid to use will depend on the patient`s medical history, the type of surgery, drug availability, any locally devised protocols and, often, individual anaesthetic preference. The pharmacology of these agents changes during early life and these changes are not consistent between different drugs. When using a particular opioid in neonates and infants it is important to understand the pharmacology of that particular drug in those age groups to ensure both efficacy and safety.

Morphine remains the most commonly used opioid and, consequently, is the most studied. Morphine clearance is decreased and the elimination half-life is increased in neonates compared with infants and older children. Also in neonates the glucuronidation pathways, the main metabolic pathway for morphine, are still developing slowing morphine metabolism and giving a relatively increased production of morphine-6-glucuronide, an active metabolite of morphine. These differences may to some extent account for the increased efficacy of morphine seen clinically in neonates. Codeine however, another popular opioid in neonates and infants, works via metabolism to morphine. The cytochrome P450 enzyme responsible for this conversion shows markedly reduced activity at these ages compared with that seen in older children and adults. Thus it maybe that little or no morphine is produced from a dose of codeine. This may explain codeine`s good safety profile in young children but may also suggest that the analgesic efficacy is questionable.

Many routes for the administration of opioids are available in children. During surgery, with an intravenous cannula in situ, the intravenous route is the easiest. In terms of bioavailability and consistency of effect it is also the most reliable. For these reasons it is usually the route of choice postoperatively, especially after major surgery. Safety, however, must always be a priority. Potentially serious complications such as over sedation and respiratory depression can occur even when using well constructed protocols for opioid use. With infusion or bolus techniques safe practice must include the presence of appropriately educated staff and regular observation of sedation and respiratory rate. Oxygen and opioid antagonists should be easily accessible in case of emergency. If these are not available then other routes of administration or analgesic strategies are indicated. It is sensible for each institution to devise protocols for opioid use dependent on their own local resources.

Oral and rectal formulations of many opioids are available and have a place for some patients in the perioperative period, especially if safety is a prohibitive local issue for other methods of delivery. If the intravenous route is available postoperatrively continuous intravenous infusions and intermittent intravenous bolus` have been shown to be safe and effective. Though where local resources allow, intravenous opioids are usually administered via patient (PCA) or nurse (NCA) controlled delivery systems which demonstrate good efficacy and safety in all age groups, even neonates. The subcutaneous route remains an alternative to intravenous administration but absorption is not as reliable and it should not be used in hypovolaemic patients. Intramuscular injection demonstrates slow absorption and unreliable effect and is considered undesirable in the awake child due to the pain and distress of the injection. Other routes of administration are available, e.g. sublingual, transdermal and intranasal and maybe appropriate in specific cases or where local resources dictate their use. Opioids are also commonly used as adjuncts to local anaesthetics.

The extensive study and use of morphine in all age groups has lead to the formulation of safe and effective dosing strategies in children, provided appropriate monitoring is used:


Titrated loading dose of i.v. morphine

50mcg/kg increments, repeated up to x4

Ongoing bolus dose of i.v. morphine

20mcg/kg per bolus, repeated to effect

Oral Morphine*

80mcg/kg 4hourly (1month – 1yr)

200 – 400 mcg/kg 4 hourly (>1yr)

I.V. or s.c. morphine infusion

10 – 40mcg/kg/hr

PCA with morphine

Bolus dose 10 – 20mcg/kg

Lockout interval 5min

Background infusion 0 – 4mcg/kg/hr

NCA with morphine

Bolus dose 10 – 20mcg/kg

Lockout interval 20 - 30min

Background infusion 4 – 20mcg/kg/hr**


* Can be used in neonates at 80mcg/kg but may need to increase dosage interval to 6 hourly and child must be closely monitored.
**For neonates a background dose is omitted to reduce the possibility of a prolonged effect of the morphine. This allows the carer to use the bolus function to titrate the analgesia and anticipate painful episodes,


Local Anaesthetics (see TOTW local anaesthetic blocks)

Local anaesthetic agents work by blocking the conduction of nociceptive stimuli along the pain pathway. This can be achieved by many different routes, the commonest being central/regional blocks, plexus blocks, peripheral nerve blocks, infiltration at the site of injury and topical application. Some method of nerve blockade is appropriate for nearly all surgical procedures and forms an important part of a balanced analgesic technique. Though, once again, the technique used will depend on the patient’s medical history, the type of surgery, any locally devised protocols and, often, individual anaesthetic preference.

Regional analgesia produces excellent perioperative analgesia for major surgery at all age groups, even preterm neonates, and has been shown to decrease postoperative complications. The evidence for this, however, is limited as is the evidence for the risks associated with paediatric epidural analgesia. In general these techniques should only be performed by experienced practioners with appropriately trained staff and protocols and monitoring guidelines available for the postoperative period. Plexus or peripheral nerve blocks have been shown to have good efficacy and safety for limb and head and neck surgery. In some procedures involving the lower limbs the analgesia obtained from a peripheral nerve block has a much longer duration of action than that obtained from a single shot central block.

For many years bupivacaine has been the local anaesthetic of choice in paediatric practice. It has been extensively studied and safe-dosing guidelines have been established which have greatly reduced the incidence of systemic toxicity. Neonates demonstrate decreased clearance and decreased protein binding of local anaesthetic agents. Therefore, at this age, there is a risk of systemic toxicity and dosing schedules have to be adjusted. Although thankfully rare, bupivaciane still carries the risk of significant carditoxicity and this has lead to the increasing introduction of the newer agents, ropivacaine and levo-bupivacaine (chirocaine), into current practice. There are now sufficient paediatric data to recommend either of these agents. Adjuncts such as opioids, adrenaline, ketamine and clonidine are commonly added to local anaesthetic agents. This is mainly seen with regional/central blockade. They allow for increased duration and spread of the block with minimal increase in side-effects, due to the low doses used.

Dosing guide for bupivacaine, levobupivacaine and ropivacaine:

Single bolus injection

Maximum dosage

Neonates

2mg/kg

Children

2.5mg/kg

Continuous Infusion

Maximum infusion rate

Neonates

0.25mg/kg/hr

Children

0.5mg/kg/hr


Discharge from Hospital

A sensible analgesic plan should include provision for analgesia to continue once the child has been discharged from hospital. Clear and easy to follow instructions should be given to aid compliance and thus efficacy. Inadequate pain relief at home, as in hospital, will lead to unacceptable distress for both child and carer and the potential for complications. In general an assessment is needed of the likely severity and duration of the pain. Again a multi-modal approach should be adopted and regular dosing schedules are superior to “as required” prescriptions when the pain is likely to be significant.

If a single bolus local anaesthetic technique has been used then the time that this will wear off must be anticipated and analgesic provision made. Often analgesia is required for a significant period of time after discharge. For instance it is well described that children still experience significant pain 7-10 days following adenotonsillectomy.


Suggested Reading



1. Lonnqvist P-A, Morton NS. Postoperative analgesia in infants and children. Br J Anaesth 2005; 95: 59 – 68
2. Berde CB, Sethna NF. Analgesics for the Treatment of Pain in Children. N Engl J Med 2002; 347: 1094 – 1103
3. Howard RF, Lloyd-Thomas A. Pain management in children. In: Sumner E and Hatch DJ eds. Paediatric Anaesthesia. London, U.K. Arnold. 1999.


Figure 1. Wong-Baker Faces Pain Rating Scale From Hockenberry MJ, Wilson D, Winkelstein ML: Wong's Essentials of Pediatric Nursing, ed. 7, St. Louis, 2005, p. 1259.




Answers to questions:


1. Paracetamol, NSAID’s, opioids, local anaesthetics
2. See text
3. Oral, rectal, intravenous
4. 20 mg/kg
5. a, b,and c are all correct, but other analgesics will probably need to be given in moderate and severe pain when paracetamol is synergistic with NSAID drugs and will reduce the amount of opioids needed, but not enough on it’s own.
6. See text
7. See text
8. Oral, rectal, intravenous, topical
9. More efficacious, so less is needed. See text
10. Over-sedation and respiratory depression, so patients given opioids should always be carefully monitored poet-operatively.
11. See text.

 Click here for a pdf of this tutorial
ArticleDate:20060328
SiteSection: Article
 
   
    
                                            
  Posting rules

     To view or add comments you must be a registered user and login  




Login Status  

You are not currently logged in.
UK/Ireland Registration
Overseas Registration

  Forgot your password?



AnaesthesiaUK and World Anaesthesia offer you Tutorial of the Week Archives







 
All rights reserved © 2021. Designed by AnaesthesiaUK.

{Site map} {Site disclaimer} {Privacy Policy} {Terms and conditions}

 Like us on Facebook 

vp